BRIGHT URO, INC.

Irvine, CA · Founded 2021 · Medtech · Private

UroMonitor: a wireless, catheter-free urodynamics diagnostic device that measures bladder function without invasive catheters

Claim this profile

Follows are private to you and power your alerts

Updated · gleanuds.com

Sector
Medtech
Headquarters
Irvine, CA
Founded
2021
Latest Form D
$14.7M, Jul 2025
Total capital
$30.8M
Federal grants
$3.1M
3 awards · 2021–2023
Rank in peer group#324 of 538
Private capital raised
$27.7M
2 Form D · last Jul 2025
16 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
7 pending · first 2024
Rank in peer group#97 of 538

Capital timeline

20212022202320242025FEDERAL ↑EQUITY ↓Cumulative $30.8M$2.1M$998K$54K1st Form D$13M2nd Form D$14.7M
20212022202320242025FEDERAL ↑EQUITY ↓Cumulative $30.8M$2.1M$998K$54K1st Form D$13M2nd Form D$14.7M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$14.7M
  • Private capital raisedForm D · SEC · 1st filing$13M
  • Federal grantHealth and Human S · Phase II · Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting$54K
  • Federal grantHealth and Human S · Phase II · Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting$998K
  • Federal grantHealth and Human S · Phase II · Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting$2.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

26months

from BRIGHT URO, INC.’s first federal award to its first private round.

First federal award · Sep 2021
Health and Human S · $2.1M
First Form D · Dec 2023
$13M · 1st Form D
Awards before first raise
3 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#97 · top 18%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Derek HerreraResearcherExecutive Officer, DirectorLinked by 5 patents · $3.1M in grants as PI
  • Kevin HerschbergerExecutive OfficerNamed in SEC Form D filings
  • Kevin HershbergerExecutive OfficerNamed in SEC Form D filings
  • Kurt AzarbarzinDirectorNamed in SEC Form D filings
  • Martha AronsonDirectorNamed in SEC Form D filings
  • Michael FrazzetteDirectorNamed in SEC Form D filings
Show all 8 people
  • Mike FrazzetteDirectorNamed in SEC Form D filings
  • Sherman WilliamsDirectorNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 13
Show all 13 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .